Literature DB >> 8314991

High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas' disease.

T K Matsumoto1, S Hoshino-Shimizu, P M Nakamura, H F Andrade, E S Umezawa.   

Abstract

The serodiagnosis of Chagas' disease, a highly prevalent disorder in South American countries, is usually made by the detection of antibodies to Trypanosoma cruzi epimastigote antigen. In this study, we assess the diagnostic performance of the immunofluorescence test with T. cruzi (Y strain) amastigote antigen from an LLC-MK2-infected cell supernatant in comparison with a test with the conventional epimastigote antigen. A total of 238 serum samples from patients in the acute and chronic phases of the disease, with the chronic indeterminate, cardiac, and digestive forms, and from nonchagasic individuals were tested for the presence of immunoglobulin G (IgG), IgM, and IgA antibodies. The reactivity of the amastigote antigen in terms of geometric mean titers was 2 to 4 times higher than that of the epimastigote antigen. Clear-cut results were obtained with the amastigote antigen, with no overlapping of true and false positives. IgG antibodies to amastigotes were found in all patients with Chagas' disease, whereas all sera from nonchagasic patients were negative, except for those from patients with visceral leishmaniasis, in which 63% cross-reactivity was observed. IgM antibodies to amastigotes were detected in 100% of sera from patients with acute Chagas' disease and in 7.5% of sera from patients with chronic Chagas' disease, whereas IgA antibodies were found in 60% of sera from patients in the acute phase and in 33% of sera from patients in the chronic phase. Despite the cross-reactivity observed with sera from visceral leishmaniasis patients, the IgG immunofluorescence test with the amastigote antigen had the highest sensitivity, specificity, and efficiency. No relationship was observed between the class-specific antibodies or their titers and the clinical forms of patients in the chronic phase. Amastigotes from the cell culture supernatant proved to be useful as an alternative antigen to epimastigotes because of their high resolution in the serodiagnosis of Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8314991      PMCID: PMC265566          DOI: 10.1128/jcm.31.6.1486-1492.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Rheumatoid factors as a cause for false positive IgM anti-toxoplasma fluorescent tests. A technique for specific results.

Authors:  M E Camargo; P G Leser; A Rocca
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1972 Sep-Oct       Impact factor: 1.846

2.  Fluorescent antibody test for the serodiagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test.

Authors:  M E Camargo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1966 Sep-Oct       Impact factor: 1.846

Review 3.  Immunity to Trypanosoma cruzi.

Authors:  Z Brener
Journal:  Adv Parasitol       Date:  1980       Impact factor: 3.870

4.  Comparison of cell culture with epimastigote antigens of Trypanosoma cruzi.

Authors:  A A Gam; F A Neva
Journal:  Am J Trop Med Hyg       Date:  1977-01       Impact factor: 2.345

5.  Characterization of stages and strains of Trypanosoma cruzi by analysis of cell membrane components.

Authors:  F G Araujo; J S Remington
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

6.  Anti-Trypanosoma cruzi IgM antibodies as serological evidence of recent infection.

Authors:  M E Camargo; V Amato Neto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1974 Jul-Aug       Impact factor: 1.846

7.  Use of antigen preparations of the amastigote stage of Trypanosoma cruzi in the serology of Chagas' disease.

Authors:  F G Araujo; D Guptill
Journal:  Am J Trop Med Hyg       Date:  1984-05       Impact factor: 2.345

8.  [Standardization of serological tests for Chagas disease: an immunoenzymatic test for blood donors triage].

Authors:  A W Ferreira; Z R Belem; M E Moura; M E Camargo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1991 Mar-Apr       Impact factor: 1.846

9.  A comparison of a new antigen from amastigotes of Trypanosoma cruzi and an antigen from epimastigotes for the diagnosis of Chagas' disease by the indirect immunofluorescence test.

Authors:  J A Cerisola; M Alvarez; M Bock; D Wegner
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1971 May-Jun       Impact factor: 1.846

10.  A complement-fixing antigen from Trypanosoma cruzi grown in cell cultures.

Authors:  F A Neva; A A Gam
Journal:  Am J Trop Med Hyg       Date:  1977-01       Impact factor: 2.345

View more
  5 in total

1.  Development and comparison of enzyme immunoassays for diagnosis of Chagas' disease using fixed forms of Trypanosoma cruzi (Epimastigotes, Amastigotes, and Trypomastigotes) and assessment of antigen stability for the three assays.

Authors:  Mariolga Berrizbietia; Momar Ndao; Marcelo Gottschalk; Alberto Aché; Fabio Vásquez; Sonia Lacouture; Mehudy Medina; Brian J Ward
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

2.  Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America.

Authors:  E S Umezawa; S F Bastos; M E Camargo; L M Yamauchi; M R Santos; A Gonzalez; B Zingales; M J Levin; O Sousa; R Rangel-Aldao; J F da Silveira
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 3.  Neuroparasitic infections: cestodes, trematodes, and protozoans.

Authors:  M D Walker; J R Zunt
Journal:  Semin Neurol       Date:  2005-09       Impact factor: 3.420

4.  Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease.

Authors:  E S Umezawa; M S Nascimento; N Kesper; J R Coura; J Borges-Pereira; A C Junqueira; M E Camargo
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

5.  High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' disease.

Authors:  M E Solana; A M Katzin; E S Umezawa; C S Miatello
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.